These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12086901)

  • 1. Staging of pancreatic cancer before and after neoadjuvant chemoradiation.
    White RR; Paulson EK; Freed KS; Keogan MT; Hurwitz HI; Lee C; Morse MA; Gottfried MR; Baillie J; Branch MS; Jowell PS; McGrath KM; Clary BM; Pappas TN; Tyler DS
    J Gastrointest Surg; 2001; 5(6):626-33. PubMed ID: 12086901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.
    White R; Lee C; Anscher M; Gottfried M; Wolff R; Keogan M; Pappas T; Hurwitz H; Tyler D
    Ann Surg Oncol; 1999; 6(1):38-45. PubMed ID: 10030414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?
    Kim HJ; Czischke K; Brennan MF; Conlon KC
    J Gastrointest Surg; 2002; 6(5):763-9. PubMed ID: 12399067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas.
    White RR; Hurwitz HI; Morse MA; Lee C; Anscher MS; Paulson EK; Gottfried MR; Baillie J; Branch MS; Jowell PS; McGrath KM; Clary BM; Pappas TN; Tyler DS
    Ann Surg Oncol; 2001 Dec; 8(10):758-65. PubMed ID: 11776488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemoradiation and duration of chemotherapy before surgical resection for pancreatic cancer: does time interval between radiotherapy and surgery matter?
    Chen KT; Devarajan K; Milestone BN; Cooper HS; Denlinger C; Cohen SJ; Meyer JE; Hoffman JP
    Ann Surg Oncol; 2014 Feb; 21(2):662-9. PubMed ID: 24276638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.
    Wagner M; Antunes C; Pietrasz D; Cassinotto C; Zappa M; Sa Cunha A; Lucidarme O; Bachet JB
    Eur Radiol; 2017 Jul; 27(7):3104-3116. PubMed ID: 27896469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine preoperative restaging CTs after neoadjuvant chemoradiation for locally advanced rectal cancer are low yield: a retrospective case study.
    Davids JS; Alavi K; Andres Cervera-Servin J; Choi CS; Sturrock PR; Sweeney WB; Maykel JA
    Int J Surg; 2014 Dec; 12(12):1295-9. PubMed ID: 25448648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.
    Turrini O; Ychou M; Moureau-Zabotto L; Rouanet P; Giovannini M; Moutardier V; Azria D; Delpero JR; Viret F
    Eur J Surg Oncol; 2010 Oct; 36(10):987-92. PubMed ID: 20828979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy.
    Mellon EA; Jin WH; Frakes JM; Centeno BA; Strom TJ; Springett GM; Malafa MP; Shridhar R; Hodul PJ; Hoffe SE
    Acta Oncol; 2017 Mar; 56(3):391-397. PubMed ID: 27885876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete pathological response following down-staging chemoradiation in locally advanced pancreatic cancer: challenging the boundaries.
    Khan AZ; Pitsinis V; Mudan SS
    World J Gastroenterol; 2007 Dec; 13(47):6433-5. PubMed ID: 18081235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of laparoscopic staging in the treatment of pancreatic cancer.
    Jimenez RE; Warshaw AL; Rattner DW; Willett CG; McGrath D; Fernandez-del Castillo C
    Arch Surg; 2000 Apr; 135(4):409-14; discussion 414-5. PubMed ID: 10768705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
    Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
    Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.
    Evans DB; Varadhachary GR; Crane CH; Sun CC; Lee JE; Pisters PW; Vauthey JN; Wang H; Cleary KR; Staerkel GA; Charnsangavej C; Lano EA; Ho L; Lenzi R; Abbruzzese JL; Wolff RA
    J Clin Oncol; 2008 Jul; 26(21):3496-502. PubMed ID: 18640930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation.
    Wayne JD; Abdalla EK; Wolff RA; Crane CH; Pisters PW; Evans DB
    Oncologist; 2002; 7(1):34-45. PubMed ID: 11854545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation.
    Katz MH; Varadhachary GR; Fleming JB; Wolff RA; Lee JE; Pisters PW; Vauthey JN; Abdalla EK; Sun CC; Wang H; Crane CH; Lee JH; Tamm EP; Abbruzzese JL; Evans DB
    Ann Surg Oncol; 2010 Jul; 17(7):1794-801. PubMed ID: 20162463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemoradiation in resectable pancreatic cancer.
    Chandler NM; Canete JJ; Stuart KE; Callery MP
    J Hepatobiliary Pancreat Surg; 2003; 10(1):61-6. PubMed ID: 12918459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas.
    Mehta VK; Fisher G; Ford JA; Poen JC; Vierra MA; Oberhelman H; Niederhuber J; Bastidas JA
    J Gastrointest Surg; 2001; 5(1):27-35. PubMed ID: 11309645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative prediction of complete resection in pancreatic cancer.
    Shah D; Fisher WE; Hodges SE; Wu MF; Hilsenbeck SG; Charles Brunicardi F
    J Surg Res; 2008 Jun; 147(2):216-20. PubMed ID: 18498873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Locally advanced pancreatic adenocarcinoma. Chemoradiotherapy, reevaluation and secondary resection].
    Delpero JR; Turrini O
    Cancer Radiother; 2006 Nov; 10(6-7):462-70. PubMed ID: 16987678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.